Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
6
-
Total shares
-
426
-
Shares change
-
-196M
-
Total reported value, excl. options
-
$49.4K
-
Value change
-
-$22.7B
-
Number of buys
-
1
-
Number of sells
-
-451
-
Price
-
$115.71
Significant Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q4 2023
6 filings reported holding HZNP - HORIZON THERAPEUTICS PLC - COMMON STOCK-FO as of Q4 2023.
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 426 shares
.
Largest 10 shareholders include IFP Advisors, Inc (332 shares), Ronald Blue Trust, Inc. (42 shares), Valued Wealth Advisors LLC (28 shares), Financial Synergies Wealth Advisors, Inc. (13 shares), Beacon Capital Management, LLC (10 shares), HUNTINGTON NATIONAL BANK (1 shares), Prestige Wealth Management Group LLC (0 shares), TD Waterhouse Canada Inc. (0 shares), GOLDMAN SACHS GROUP INC (0 shares), and China Universal Asset Management Co., Ltd. (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.